BCH4024 OC Sp25 E2 Q28: Promising drugs have been developed…
BCH4024 OC Sp25 E2 Q28: Promising drugs have been developed to treat invasive cancers. A class of these drugs act as competitive inhibitors of ATP binding to active sites of receptor tyrosine kinases (RTKs). What are some possible downstream effects of RTK activation in healthy cells?